Placebo+SOC

DRUG2 trials

Sponsors

BioCryst Pharmaceuticals, NOxy Health Products, LLC

Conditions

CoughDiabetic Foot UlcerFeverHeadacheNasal CongestionSeasonal InfluenzaSore Throat

Phase 1

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)

SuspendedNCT06020664

NOxy Health Products, LLCDiabetic Foot Ulcer

Start: 2023-08-16End: 2024-11-24Target: 30Updated: 2024-01-16

Phase 3

A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

TerminatedNCT00958776

BioCryst PharmaceuticalsCough, Fever, Headache +3

Start: 2009-11-30End: 2013-10-31Updated: 2015-02-12

Related Papers

Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

Clinical Infectious Diseases2014-08-12112 citations